Can Bellicum Pharmaceuticals Stock Bounce Back?
How you view a stock depends heavily on your point of reference. Bellicum Pharmaceuticals (NASDAQ: BLCM), for example, saw its share price fall nearly 14% in one day in late June. That's certainly not great, but it's not disastrous, either.
On the other hand, if you bought the biotech stock back in mid-November of last year, you've suffered through seeing roughly half of your initial investment evaporate. Many investors might view that kind of plunge as catastrophic.
Whenever you bought Bellicum (or if you haven't invested in the biotech but are considering doing so), there's one overriding question: Can the stock bounce back? Here's why the answer is a tentative "yes."
Source: Fool.com